Improving diagnosis of sepsis with early recognition of AMR

Post-pandemic, hospital-onset infections from resistant pathogens have surged, with significant increases in carbapenem-resistant, ESßL-producing, and multidrug-resistant infections. Antimicrobial resistance (AMR) and its impact on sepsis, a condition affecting 49 million people and causing 11 million deaths annually, urgently needs to be addressed. Download this resource to discover how Beckman Coulter’s MicroScan systems provide accurate, timely resistance detection, supporting better antimicrobial therapy decisions to combat this costly and deadly condition.